Previous Article | Next Article 
Journal of Clinical Microbiology, November 1999, p. 3718-3721, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Effects of OspA Vaccination on Lyme Disease
Serologic Testing
Maria E.
Aguero-Rosenfeld,1,*
Janet
Roberge,2
Carol A.
Carbonaro,2
John
Nowakowski,3
Robert B.
Nadelman,3 and
Gary P.
Wormser3
Department of
Pathology,1 and Division of Infectious
Diseases, Department of Medicine,3 New York
Medical College, and Westchester Medical
Center,2 Valhalla, New York 10595
Received 7 May 1999/Returned for modification 15 July 1999/Accepted 11 August 1999
This study presents the effects of OspA vaccination on two-step
testing for Borrelia burgdorferi antibodies. Although
vaccinees developed enzyme-linked immunosorbent assay reactivity,
immunoblots did not fulfill Centers for Disease Control and Prevention
criteria for positivity. Furthermore, OspA reactivity did not interfere with interpretation of immunoblots with sera from patients who developed early Lyme disease despite vaccination.
*
Corresponding author. Mailing address: Clinical
Laboratories, Room 1J-11a, Westchester Medical Center, Valhalla, NY
10595. Phone: (914) 493-7389. Fax: (914) 493-5742. E-mail:
maria_aguero-rosenfeld{at}nymc.edu.
Journal of Clinical Microbiology, November 1999, p. 3718-3721, Vol. 37, No. 11
0095-1137/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Aguero-Rosenfeld, M. E., Wang, G., Schwartz, I., Wormser, G. P.
(2005). Diagnosis of Lyme Borreliosis. Clin. Microbiol. Rev.
18: 484-509
[Abstract]
[Full Text]
-
Fawcett, P. T., Rose, C. D., Maduskuie, V.
(2004). Long-Term Effects of Immunization with Recombinant Lipoprotein Outer Surface Protein A on Serologic Test for Lyme Disease. CVI
11: 808-810
[Abstract]
[Full Text]
-
Hefty, P. S., Brooks, C. S., Jett, A. M., White, G. L., Wikel, S. K., Kennedy, R. C., Akins, D. R.
(2002). OspE-Related, OspF-Related, and Elp Lipoproteins Are Immunogenic in Baboons Experimentally Infected with Borrelia burgdorferi and in Human Lyme Disease Patients. J. Clin. Microbiol.
40: 4256-4265
[Abstract]
[Full Text]
-
Marques, A. R., Martin, D. S., Philipp, M. T.
(2002). Evaluation of the C6 Peptide Enzyme-Linked Immunosorbent Assay for Individuals Vaccinated with the Recombinant OspA Vaccine. J. Clin. Microbiol.
40: 2591-2593
[Abstract]
[Full Text]
-
Smith, R. P., Schoen, R. T., Rahn, D. W., Sikand, V. K., Nowakowski, J., Parenti, D. L., Holman, M. S., Persing, D. H., Steere, A. C.
(2002). Clinical Characteristics and Treatment Outcome of Early Lyme Disease in Patients with Microbiologically Confirmed Erythema Migrans. ANN INTERN MED
136: 421-428
[Abstract]
[Full Text]
-
Reed, K. D.
(2002). Laboratory Testing for Lyme Disease: Possibilities and Practicalities. J. Clin. Microbiol.
40: 319-324
[Full Text]
-
Gomes-Solecki, M. J. C., Wormser, G. P., Schriefer, M., Neuman, G., Hannafey, L., Glass, J. D., Dattwyler, R. J.
(2002). Recombinant Assay for Serodiagnosis of Lyme Disease Regardless of OspA Vaccination Status. J. Clin. Microbiol.
40: 193-197
[Abstract]
[Full Text]
-
Fawcett, P. T., Rose, C. D., Budd, S. M., Gibney, K. M.
(2001). Effect of Immunization with Recombinant OspA on Serologic Tests for Lyme Borreliosis. CVI
8: 79-84
[Abstract]
[Full Text]